Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Carperitide by Daiichi Sankyo for Contrast Induced Nephropathy: Likelihood of Approval
Carperitide is under clinical development by Daiichi Sankyo and currently in Phase II for Contrast Induced Nephropathy. According to GlobalData,...